GT
Grace Therapeutics, Inc.
🇺🇸XNAS.GRCEUnited StatesHealthcare
$2.17USDdown -0.12 (-5.24%)OpenEnd of day3:16 PM
Price$2.17-0.12 (-5.24%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00439U1043
- CUSIP
- 00439U104
Company
- Employees
- 5
- Headquarters
- Princeton, United States
- Website
- https://www.gracetx.com
- CEO
- Mr. Prashant Kohli
Market
- Shares outstanding
- 21M
- Market cap
- $45.65M
Highlights
- Market cap
- $45.65M
- EPS LTM
- -$1.24
- P/E LTM
- -1.83
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$21.45M-80.83%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$10.3M+21.42%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.